• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Fayette Underwood, USA

    Fayette Underwood, USA

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Barry de Reuver, Netherlands

    Barry de Reuver, Netherlands

  • Mike Small, UK

    Mike Small, UK

  • Ana Lilia Rodriguez, Mexico

    Ana Lilia Rodriguez, Mexico

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Willi Klein, UK

    Willi Klein, UK

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Sanjay Kumar Srivastava, India

    Sanjay Kumar Srivastava, India

  • Philip Brindle, England

    Philip Brindle, England

  • Angie Bordaen, Belgium

    Angie Bordaen, Belgium

  • Hollister

    Hollister
    hollister

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • Orly Dichoso, Canada

    Orly Dichoso, Canada

  • Andrea Zicchieri, Italy

    Andrea Zicchieri, Italy
    AndreaZicchieri_conSLAncioItaly

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Marcel R. Wernard, Netherlands

    Marcel R. Wernard, Netherlands

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Ywan Dierick, Belgium

    Ywan Dierick, Belgium

  • Ann Nicol, USA

    Ann Nicol, USA

  • Conny van der Meijden, Netherlands

    Conny van der Meijden, Netherlands

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Aida Trzmiel de Guterman, Argentina

    Aida Trzmiel de Guterman, Argentina

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Bob Spurrier, USA

    Bob Spurrier, USA

  • Chris McCauley, Canada

    Chris McCauley, Canada

  • Inta Grubb, Australia

    Inta Grubb, Australia

  • Anita Forte, USA

    Anita Forte, USA

  • Alberto Baez Murillo, Colombia

    Alberto Baez Murillo, Colombia

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Mirca Bersani, Italy

    Mirca Bersani, Italy
    MircaBersani

  • Chih Ching Darren Wong, Malaysia

    Chih Ching Darren Wong, Malaysia

  • Monica Soriano, Argentina

    Monica Soriano, Argentina

  • Vincent Bourque, Canada

    Vincent Bourque, Canada
    vincent_bourque

  • Mona H. Bahus and Camilla Knoff Glomstad, Norway

    Mona H. Bahus and Camilla Knoff Glomstad, Norway

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Gisli Jonasson, Iceland

    Gisli Jonasson, Iceland

  • Bob Simonds, USA

    Bob Simonds, USA

  • Ali Var, Turkey

    Ali Var, Turkey

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login